These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 12746247)

  • 1. Estimating the relative risk in cohort studies and clinical trials of common outcomes.
    McNutt LA; Wu C; Xue X; Hafner JP
    Am J Epidemiol; 2003 May; 157(10):940-3. PubMed ID: 12746247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.
    Zhang J; Yu KF
    JAMA; 1998 Nov; 280(19):1690-1. PubMed ID: 9832001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".
    Deddens JA; Petersen MR
    Am J Epidemiol; 2004 Jan; 159(2):213-4; author reply 214-5. PubMed ID: 14718224
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".
    Karp I
    Am J Epidemiol; 2014 Apr; 179(8):1034-5. PubMed ID: 24553682
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".
    Cummings P
    Am J Epidemiol; 2004 Jan; 159(2):213; author reply 214-5. PubMed ID: 14718225
    [No Abstract]   [Full Text] [Related]  

  • 6. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes.
    Robbins AS; Chao SY; Fonseca VP
    Ann Epidemiol; 2002 Oct; 12(7):452-4. PubMed ID: 12377421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk ratios and odds ratios for common events in cross-sectional and cohort studies.
    Wilber ST; Fu R
    Acad Emerg Med; 2010 Jun; 17(6):649-51. PubMed ID: 20624147
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistical Issues in Estimation of Adjusted Risk Ratio in Prospective Studies.
    Janani L; Mansournia MA; Nourijeylani K; Mahmoodi M; Mohammad K
    Arch Iran Med; 2015 Oct; 18(10):713-9. PubMed ID: 26443254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down with odds ratios: risk ratios in cohort studies and randomised clinical trials].
    Knol MJ
    Ned Tijdschr Geneeskd; 2012; 156(28):A4775. PubMed ID: 22805792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.
    Localio AR; Margolis DJ; Berlin JA
    J Clin Epidemiol; 2007 Sep; 60(9):874-82. PubMed ID: 17689803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A set of SAS macros for calculating and displaying adjusted odds ratios (with confidence intervals) for continuous covariates in logistic B-spline regression models.
    Gregory M; Ulmer H; Pfeiffer KP; Lang S; Strasak AM
    Comput Methods Programs Biomed; 2008 Oct; 92(1):109-14. PubMed ID: 18603325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Odds Ratio: review about the meaning of an epidemiological measure].
    Aguiar P; Nunes B
    Acta Med Port; 2013; 26(5):505-10. PubMed ID: 24192088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized binomial models for risk or prevalence ratios and differences.
    Richardson DB; Kinlaw AC; MacLehose RF; Cole SR
    Int J Epidemiol; 2015 Oct; 44(5):1660-72. PubMed ID: 26228585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical note: The risk ratio, an alternative to the odds ratio for estimating the association between multiple risk factors and a dichotomous outcome.
    Ospina PA; Nydam DV; DiCiccio TJ
    J Dairy Sci; 2012 May; 95(5):2576-84. PubMed ID: 22541486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating risk ratio from any standard epidemiological design by doubling the cases.
    Ning Y; Lam A; Reilly M
    BMC Med Res Methodol; 2022 May; 22(1):157. PubMed ID: 35637431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures and their application in clinical trials for retinal degenerative diseases: outline, review, and perspective.
    Fishman GA; Jacobson SG; Alexander KR; Cideciyan AV; Birch DG; Weleber RG; Hood DC
    Retina; 2005 Sep; 25(6):772-7. PubMed ID: 16141867
    [No Abstract]   [Full Text] [Related]  

  • 17. The likelihood as statistical evidence in multiple comparisons in clinical trials: no free lunch.
    Korn EL; Freidlin B
    Biom J; 2006 Jun; 48(3):346-55. PubMed ID: 16845900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The authors reply.
    McNutt LA; Wu C; Xue X; Hafner JP
    Am J Epidemiol; 2014 Apr; 179(8):1035-6. PubMed ID: 24671073
    [No Abstract]   [Full Text] [Related]  

  • 19. Methods of evaluation in outcomes research.
    Reed PJ
    Am J Manag Care; 1998 Nov; 4(11):1616-25; quiz 1626-7. PubMed ID: 10338907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.
    Walters SJ
    Health Qual Life Outcomes; 2004 May; 2():26. PubMed ID: 15161494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.